Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies

Published:2021-11-12 Issue:12 Volume:5 Page:e664
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Pflug Natali,Chakupurakal Geothy,Fink Anna-Maria,Robrecht Sandra,Herling Marco,Cramer Paula,Holtick Udo,Theurich Sebastian,Schetelig Johannes,Fischer Kirsten,Ritgen Matthias,Scheid Christof,Eichhorst Barbara,Dreger Peter,Hallek Michael,von Bergwelt-Baildon Michael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference16 articles.

1. Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.;Mato;Haematologica,2018

2. BTK(C481S)-mediated resistance to ibrutinib in chronic lymphocytic leukemia.;Woyach;J Clin Oncol,2017

3. Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents.;Roeker;Blood Adv,2020

4. Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation.;van Gelder;Bone Marrow Transplant,2017

5. Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells.;Patz;Br J Haematol,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP